At the news
? NEUTRALIMPACT 2/10 CLUSTER filed Jun 12, 2026 at 17:27 ET
Two directors at Ligand Pharmaceuticals sold a combined ~$1.31M in shares over two days, representing 0.026% of the company's $5.1B market cap. These open-market sales are trivial relative to market cap and likely reflect routine portfolio diversification, no material signal for the stock.
- Director Aryeh Jason sold 5,000 shares total on June 10-11, 2026 (~$1.25M)
- Director John L. Lamattina sold 257 shares on June 10, 2026 (~$63.5K)
- Total insider sales of ~$1.31M represent only 0.026% of LGND's $5.1B market cap
- All sellers are directors, not C-suite executives, signal weight is lower per academic literature
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access